Public IPO catalogue · Read-only · No enquiries, bids or payments are accepted
PUBLIC IPO CATALOGUE · READ-ONLY · NO SUBMISSIONS
India BoardINR (₹)

CURATED IPO DIRECTORY / READ-ONLY

India IPO Visibility Board

Browse IPO profiles from our public catalogue. Positions are editorial; offering information may change, so check official sources before relying on it.

Listed IPOs05 / 5
CurrencyINR
Board reviewed16 Oct 2026

Manually curated from reviewed official issuer, exchange or filing sources; ordering is editorial, not investment merit or paid demand.

0 positions are unfilled.

SECTION 01 / TOP 5 EDITORIAL MOSAIC

Spotlight positions

Curated positions #01–#05
CURATED POSITION #02BSE and NSE
Source reviewed

Manufacturing · IN

Zetwerk's red herring prospectus is available from SEBI. The initial public offering is open from 15 to 19 October 2026; check the official filing for the latest terms.

Placement pricingNot available
View details
CURATED POSITION #03BSE and NSE
Source reviewed

Healthcare services · IN

Paras Health operates a network of hospitals in India. Its initial public offering is scheduled for 21–23 October 2026; review the official prospectus for the latest terms and risks.

Placement pricingNot available
View details
CURATED POSITION #04BSE and NSE
Source reviewed

Defence imaging technology · IN

Tonbo Imaging's red herring prospectus is available from SEBI. The initial public offering is open from 15 to 19 October 2026; check the official filing for the latest terms.

Placement pricingNot available
View details
CURATED POSITION #05BSE and NSE
Source reviewed

Medical devices · IN

Sahajanand Medical Technologies develops cardiovascular medical devices. Its initial public offering is open from 15 to 19 October 2026; review the official prospectus for the latest terms and risks.

Placement pricingNot available
View details
ⓘ This catalogue is read-only. Board order is editorial, not investment merit or paid demand.Back to top ↑
CURATED POSITION #00 · INDIA

IPO inspection

IPOSphere · Curated IPO discoveryPositions are editorial, not investment merit or paid demand.